Befreiender Konzernabschluss Zum Geschäftsjahr Vom 01.01.2021 Bis Zum 31.12.2021 - Dassault Systemes 3DExcite GmbHMünchen

Dassault Systemes 3DExcite GmbH

München

Befreiender Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021

Dassault Systèmes SE

Vélizy-Villacoublay Cedex/Frankreich

UNIVERSAL REGISTRATION DOCUMENT 2021

ANNUAL FINANCIAL REPORT

This document is an English-language translation of Dassault Systèmes’ Document d’enregistrement universel (Universal registration document), which was filled with the AMF (French Financial Markets Authority) on March 17, 2022, under regulation (UE) 2017/1129 without prior approval in accordance with Article 9 of such regulation. Only the French version of the Document d’enregistrement universel is legally binding.

General

This Universal registration document also includes:

•	the annual financial report to be prepared and published by every listed company within four months of the end of its fiscal year, pursuant to Article L. 451-1-2 of the Monetary and Financial Code and Article 222-3 of the French Financial Markets Authority (“AMF”) General Regulation; and
•	the annual management report of Dassault Systèmes SE’s Board of Directors, which must be provided to the General Meeting of Shareholders approving the financial statements for each completed fiscal year, pursuant to Articles L.225-100 and L. 22-10-34 et seq. of the French Commercial Code.

The index set forth on pages 293 and 294 provides cross-references to the relevant portions of these two reports.

All references to “euro” or to the symbol “€” refer to the legal currency of the French Republic and certain countries of the European Union. All references to the “U.S. dollar” or to the symbol “$” refer to the legal currency of the United States.

As used herein, “Dassault Systèmes”, the “Company”, the “Group” and “we” refer to Dassault Systèmes SE and all the companies included in the scope of consolidation.

“Dassault Systèmes SE” refers only to the European parent company of the Company, which is governed by French law.

In compliance with Article 19 of European Regulation no. 2017/1129 of the European Parliament and of the European Council, the following information is incorporated by reference in this Universal registration document:

•	the consolidated financial statements on pages 106 to 147 (inclusive), the parent company financial statements on pages 154 to 176 (inclusive), and the related audit reports on pages 148 to 152 and 178 to 182 (inclusive) of the Universal registration document for the year 2020 filed with the AMF on March 19, 2021, under no. D. 21-0159;
•	the financial information on pages 86 to 103 (inclusive) of the Universal registration document for the year 2020 filed with the AMF on March 19, 2021, under no. D. 21-0159;
•	the consolidated financial statements on pages 94 to 137 (inclusive), the parent company financial statements on pages 143 to 166 (inclusive), and the related audit reports on pages 138 to 142 and 168 to 172 (inclusive) of the Universal registration document for the year 2019 filed with the AMF on March 19, 2020, under no. D. 20-0144;
•	the financial information on pages 73 to 91 (inclusive) of the Universal registration document for the year 2019 filed with the AMF on March 19, 2020, under no. D. 20-0144.

The portions of these documents which are not incorporated herein are either not relevant for current investors, or are covered in another section of this Universal registration document.

Person Responsible

Person Responsible for the Universal registration document

Bernard Charlès - Vice chairman and Chief Executive Officer.

Certification by the Person Responsible for the Universal registration document

Vélizy-Villacoublay, March 17, 2022.

I hereby certify that the information contained in this Universal registration document is, to my knowledge, in accordance with the facts and that no information liable to affect its significance has been omitted.

I certify that, to my knowledge, the financial statements have been prepared in accordance with applicable accounting standards and give a faithful representation of the assets, financial situation and results of Dassault Systèmes SE and all the companies included in the scope of consolidation, and that the “management report”, the content of which is cross-referenced in a table at page 294, included in this Universal registration document, presents a faithful representation of the business trends, results and financial situation of Dassault Systèmes SE and all the companies included in the scope of consolidation as well as a description of the principal risks and uncertainties which they face.

1 PresentatIon of the Company

Dassault Systèmes’ Vision, Strategy and Performance

Bernard Charlès, Vice chairman of the Board and Chief Executive Officer, and Charles Edelstenne, Chairman of the Board

(All figures are non-IFRS and revenue growth rates are in constant currencies)

40 years after the creation of the company and 10 years after stating its purpose, what is Dassault Systèmes’ strategy?

Dassault Systèmes is proud of the creativity of its two generations of innovators. Our company’s 40^th anniversary is above all an opportunity to focus on our next horizon: 2040. What do we want to be recognized for in 2040? How do we intend to contribute to society? We will see two major shifts in the coming decades. First, a more sustainable, circular economy, and second, the virtualization of life sciences and healthcare. Sustainable development is the very foundation of our corporate purpose to “harmonize product, nature and life”, and is what drives our strategy. In 2020, following our decision to extend our focus “from things to life”, we put Life Sciences and Healthcare at the heart of our identity. Our ambition is to deliver the same level of leadership, excellence and performance in the living world as we do in the manufacturing industry. Following the integration of MEDIDATA, we are already the world’s leading provider of clinical trials solutions. Creating the first-ever virtual twin of the human body is our next exciting challenge and a major milestone for us all - patients, doctors and researchers alike.

This is in keeping with the legacy of Dassault Systèmes. Every decade since the outset, we have helped industrial firms disrupt how they design and make products. Starting with CATIA, designing 3D parts and assemblies and replacing physical prototypes with virtual testing. Next, we invented the virtual twin of entire complex systems, for example with Boeing to create a 3D mock-up of the 777. Lifecycle management, or the end-to-end product management from design through to recycling, including production and distribution, marked the third stage. Then, 10 years ago, we unveiled a key enabler to fulfill our purpose: the 3D EXPERIENCE platform. With this platform, customers can create virtual twin experiences that combine modeling, simulation and real-world evidence. Virtual twin experiences enable firms to take their imagination beyond the confines of the real world, offering a powerful transformation enabler for them to become the solution to today’s sustainable development challenges.

The Experience Economy, accelerated by the pandemic, triggers new expectations from citizens, patients, and consumers. For instance, tomorrow's mobility is no longer only a matter of vehicles; it is a matter of sustainable mobility experiences. Tomorrow's healthcare is much more than therapeutics; it is about the patient journey and precision medicine. Tomorrow's cities are not only a collection of buildings, streets and facilities; it is about quality of life and quality of service.

Our clients and partners are embracing the Experience Economy across our three sectors. They have made sustainability the cornerstone of their transformation.

In Manufacturing Industries, clients are stepping up their partnerships with us to virtualize their operations, improve data sharing and collaboration across their organization, reducing costs and time-to-market. In 2021, Renault Group embarked on a new stage in its technological and digital transformation by choosing the cloud-based 3D EXPERIENCE platform to develop new products and mobility services.

In Life Sciences & Healthcare, virtualization is now the catalyst and enabler of groundbreaking healthcare products and practices. This transformation is spawning new usages and offering simpler, more precise experiences for people, as part of prevention, treatment and follow-up. To close the loop between research & development and usages, we connect the dots across molecule simulation, clinical trials, manufacturing and real-world data, across researchers, manufacturers, doctors and patients, illustrated by MEDIDATA’s key role in Moderna's COVID-19 vaccine clinical trials. This opens up a new dawn in precision medicine, as it becomes more inclusive, more independent, more accessible and ultimately more effective.

Lastly, in Infrastructure & Cities, we are opening new horizons in making the construction industry more efficient and sustainable. This year, we expanded our partnership with Bouygues Construction to speed up the company’s digital transformation, improving research & development of new cloud-based, mobile-enabled approaches using the virtual twin.

To better serve our customers and achieve our strategic objectives, we are implementing our own virtual twin experience. All functions of our organization will be virtualized to provide us with a holistic view of our own processes, products, services and usages.

Could you comment on Dassault Systèmes’ 2021 performance and the outlook for 2022?

Dassault Systèmes’ performance endorses our long-term strategic vision and the investments made over the years. The company has built strong competitive advantages to...